Open Insider Trading Activity for Turning Point Therapeutics, Inc. EVP & Chief Commercial Officer Partridge Andrew John
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting TPTX | 2022-02-11 | 2022-02-09 | Turning Point Therapeutics, Inc. | Partridge Andrew John | EVP & Chief Commercial Officer | Sell | 1 | 221 | $36.30 | $8,022.30 | 0.99% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting TPTX | 2021-07-15 | 2021-07-14 | Turning Point Therapeutics, Inc. | Partridge Andrew John | EVP & Chief Commercial Officer | Sell | 1 | 1,869 | $74.90 | $139,988.10 | 7.91% | View Filing |